These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3424197)

  • 1. [The possibility of targeted pharmacological action on the intravascular binding of calcium ions: a new aspect of pharmacodynamics?].
    Kolomiets VV; Merzon KA
    Ter Arkh; 1987; 59(9):86-90. PubMed ID: 3424197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium metabolism and the diastolic rigidity status of the myocardium in patients with ischemic heart disease under the influence of calcium antagonist treatment].
    Lomakovs'kyÄ­ OM; Mkhytarian LS
    Fiziol Zh (1978); 1992; 38(1):22-6. PubMed ID: 1555721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of verapamil and nifedipine on the fractional composition of calcium in the blood serum].
    Merzon KA
    Kardiologiia; 1985 Jul; 25(7):89-93. PubMed ID: 4057747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fractional composition of serum calcium in chronic heart failure].
    Merzon KA
    Ter Arkh; 1986; 58(11):44-8. PubMed ID: 3824189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists in heart failure.
    Klugmann S; Salvi A; Camerini F
    Herz; 1983 Apr; 8(2):88-92. PubMed ID: 6852766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    LitvitskiÄ­ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in ischemic heart disease].
    Guize L
    J Mal Vasc; 1997 Oct; 22(4):222-8. PubMed ID: 9411006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Binding of cardiac glycosides by the erythrocytes of patients].
    Bakaev VV
    Farmakol Toksikol; 1986; 49(5):25-7. PubMed ID: 3770168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations].
    De Cesaris R; Balestrazzi M; Chiarappa R; Ranieri G
    G Ital Cardiol; 1983 Sep; 13(9):188-91. PubMed ID: 6662312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Biopharm Drug Dispos; 2002 Jul; 23(5):173-81. PubMed ID: 12116048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cardiac glycosides on the calcium content in the blood serum: possible mechanisms and the physiological significance].
    Merzon KA; Kolomiets VV
    Kardiologiia; 1979 Oct; 19(10):110-1. PubMed ID: 502158
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of the anti-anginal action of korinfar].
    Sadkovaia RM; Zin'kovskaia TM; Golubev AD
    Farmakol Toksikol; 1986; 49(5):90-2. PubMed ID: 3770183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving role of calcium channel blockers in heart failure.
    Pieper JA
    Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various cardiac glycosides on central hemodynamics after operations on the abdominal organs].
    Shanin SS; Zheludov EP
    Vestn Khir Im I I Grek; 1985 Nov; 135(11):107-9. PubMed ID: 4095850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.